More than 150 clinicaltrials listed on the National Institutes of Health (NIH) Website have revealed several potential benefits of stem cell implantation or infusion for the treatment of diabetes.
Exploratory modelling will use Markov models to identify variables associated with transitions between the three glycaemic states of interest, defined according to the NZ definitions: normoglycaemia (HbA1c<41 mmol/mol), pre-diabetes (41 mmol/mol≥HbA1 c ≤ 49 mmol/mol) and diabetes (HbA1c>49 mmol/mol.
They are currently enrolling people with type 1 diabetes in a clinical study to learn whether MSCs from umbilical cords transplanted into the pancreases of the disease can help their bodies produce insulin.
Release) How the diabetes drug metformin might do more than just lower glucose The widely used type 2 diabetes drug metformin is currently being investigated in more than 1,500 clinicaltrials for its potential to treat a range of diseases, from cancer to heart disease ...
Metabolic imbalance causes an increased risk of microvascular and macrovascular complications associated with the increased prevalence of cardiovascular disease (CVD) in diabetics.
What Happened Massachusetts-based KalVista, which focuses on developing small molecule protease inhibitors, said a Phase 2 study that evaluated its KVD001 in patients with diabetic macular edema, who were poor responders to previous treatment with anti-VEGF therapy, did not meet the primary and secondary endpoints.
In addition, for applications involving clinical trials: A proposed Clinical Trial application may include study design, methods, and intervention that are not by themselves innovative but address important questions or unmet needs.
The American Diabetes Association has declared that medical nutrition therapy (MNT) is integral to overall management of diabetes, and all diabetes patients should be referred to individualized MNT 2.
Glucagon‐like peptide 1 receptor agonists reduced the risk of progression to macroalbuminuria, but not severe kidney outcomes in large‐scale randomized controlled trials, suggesting that the kidney‐protective effects of glucagon‐like peptide 1 receptor agonists are limited to patients with early‐stage diabetic nephropathy.
For instance, as all diabetes patients are recommended to be screened for foot care every year 80 , early diagnostic screening examination of DPN should be carried out for all diabetes and prediabetes patients.
On this page, you see the results of the search you have run. You may also view the following:
Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format.
View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.
Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.
Show or hide the record’s caption (content description).
Show actions that can be made with the search result record.
Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.